Strategic Blueprint LLC Sells 1,112 Shares of Danaher Corporation $DHR

Strategic Blueprint LLC trimmed its holdings in shares of Danaher Corporation (NYSE:DHR) by 7.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,887 shares of the conglomerate’s stock after selling 1,112 shares during the period. Strategic Blueprint LLC’s holdings in Danaher were worth $2,743,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of DHR. GAMMA Investing LLC raised its holdings in Danaher by 22.2% in the first quarter. GAMMA Investing LLC now owns 9,126 shares of the conglomerate’s stock worth $1,871,000 after purchasing an additional 1,660 shares during the period. Pacific Capital Partners Ltd acquired a new stake in Danaher in the first quarter worth $7,175,000. GHP Investment Advisors Inc. raised its holdings in Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock worth $25,000 after purchasing an additional 99 shares during the period. International Assets Investment Management LLC raised its holdings in Danaher by 39.5% in the first quarter. International Assets Investment Management LLC now owns 2,191 shares of the conglomerate’s stock worth $449,000 after purchasing an additional 620 shares during the period. Finally, Global Assets Advisory LLC acquired a new stake in Danaher in the first quarter worth $312,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Up 2.1%

Danaher stock opened at $222.62 on Friday. The company has a market cap of $157.25 billion, a P/E ratio of 45.90, a price-to-earnings-growth ratio of 3.31 and a beta of 0.77. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $258.23. The company has a fifty day simple moving average of $202.49 and a 200 day simple moving average of $198.02. The company has a current ratio of 1.52, a quick ratio of 1.22 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. The business had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The firm’s revenue for the quarter was up 4.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.71 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Research analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is 27.23%.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on DHR shares. UBS Group cut their target price on shares of Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a report on Wednesday, July 23rd. Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a research note on Friday, June 27th. JPMorgan Chase & Co. upped their target price on shares of Danaher from $260.00 to $270.00 and gave the stock an “overweight” rating in a research note on Wednesday. Rothschild Redb lowered shares of Danaher from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 8th. Finally, Royal Bank Of Canada set a $241.00 target price on shares of Danaher in a research note on Tuesday, September 2nd. Eighteen analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $243.39.

Insider Activity at Danaher

In other news, Director Teri List sold 2,778 shares of Danaher stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 11.10% of the stock is currently owned by company insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.